Arbutus Biopharma Corp (ABUS): Shares Outstanding
192.53M
As of 2025-12-31
197.63M
As of 2026-06-30
+6.9%
3-year compound annual growth
+16.5%
5-year compound annual growth
+13.4%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 192.53M | +1.4% | 2026-03-23, Balance as of period end |
| 2024-12-31 | 189.96M | +11.8% | 2026-03-23, Balance as of period end |
| 2023-12-31 | 169.87M | +7.9% | 2025-03-27, Balance as of period end |
| 2022-12-31 | 157.46M | +8.6% | 2024-03-05, Balance as of period end |
| 2021-12-31 | 144.99M | +61.7% | 2023-03-02, Balance as of period end |
| 2020-12-31 | 89.68M | +38.4% | 2022-03-03, Balance as of period end |
| 2019-12-31 | 64.78M | +16.7% | 2021-03-04, Balance as of period end |
| 2018-12-31 | 55.52M | +0.8% | 2020-03-05, Balance as of period end |
| 2017-12-31 | 55.06M | +0.4% | 2019-03-07, Balance as of period end |
| 2016-12-31 | 54.84M | +0.5% | 2018-03-16, Balance as of period end |
| 2015-12-31 | 54.57M | +143.2% | 2017-03-22, Balance as of period end |
| 2014-12-31 | 22.44M | +17.8% | 2016-03-09, Balance as of period end |
| 2013-12-31 | 19.05M | +33.2% | 2015-03-13, Balance as of period end |
| 2012-12-31 | 14.31M | +17.8% | 2014-03-28, Balance as of period end |
| 2011-12-31 | 12.15M | +17.5% | 2013-03-27, Balance as of period end |
| 2010-12-31 | 10.34M | n/a | 2012-03-27, Balance as of period end |